| 19 0.35 (1.88%) | 09-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 22.72 | 1-year : | 26.54 |
| Resists | First : | 19.45 | Second : | 22.72 |
| Pivot price | 18.42  |
|||
| Supports | First : | 17.21 | Second : | 15.81 |
| MAs | MA(5) : | 18.32 |
MA(20) : | 18.27 |
| MA(100) : | 16.74 |
MA(250) : | 16.54 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.3  |
| %K %D | K(14,3) : | 66.9 |
D(3) : | 53.3 |
| RSI | RSI(14): 62.1 |
|||
| 52-week | High : | 19.68 | Low : | 1.39 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ TECX ] has closed below upper band by 27.6%. Bollinger Bands are 42.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 19.1 - 19.17 | 19.17 - 19.23 |
| Low: | 18.04 - 18.13 | 18.13 - 18.21 |
| Close: | 18.86 - 18.98 | 18.98 - 19.09 |
Tue, 17 Sep 2024
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 2.9% - MarketBeat
Sun, 15 Sep 2024
Atlas Venture Life Science Advisors LLC Purchases New Stake in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tue, 20 Aug 2024
Tectonic Therapeutic to Participate in September Investor Conferences - Yahoo Finance
Tue, 20 Aug 2024
Tectonic Therapeutic to Participate in September Investor Conferences - StockTitan
Wed, 14 Aug 2024
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Sun, 04 Aug 2024
Tectonic Therapeutic: Analyzing Its Post-Merger Valuation And Prospects - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 15 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 39.3 (%) |
| Held by Institutions | 43.4 (%) |
| Shares Short | 21 (K) |
| Shares Short P.Month | 14 (K) |
| EPS | -3.07 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.28 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -2.88 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -43 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -6.19 |
| PEG Ratio | 0 |
| Price to Book value | 1.68 |
| Price to Sales | 0 |
| Price to Cash Flow | -6.55 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|